Keyphrases
Prospective Cohort Study
100%
Tumor Subtype
100%
Cancer Surgery
100%
Lockdown
100%
COVID-19 Pandemic Lockdown
100%
COVID-19 Pandemic Effects
100%
Nonoperative
54%
Light Restriction
36%
COVID-19
27%
Cancer Research
18%
COVID-19 Pandemic
18%
Hazard Ratio
18%
Ireland
18%
Great Britain
18%
Coloproctology
18%
Operation Rate
18%
Planned Surgery
18%
Gynecological Cancer
9%
Acute Care
9%
Sarcoma
9%
Surgeons
9%
Cancer Types
9%
Disease Research
9%
Public Health Emergency
9%
Bowel
9%
Elective Surgery
9%
Sensitivity Analysis
9%
Upper Gastrointestinal Tract
9%
Index Score
9%
Neoadjuvant Therapy
9%
Surgery Treatment
9%
Medtronic
9%
Resilience
9%
Adjusted Hazard Ratio
9%
Curative Surgery
9%
Resectability Status
9%
Urology
9%
Patient Delay
9%
Bowel Dysfunction
9%
Cox Proportional Hazards Regression Model
9%
Long Delay
9%
European Society
9%
Solid Cancer
9%
Surgical Oncology
9%
Oxford
9%
Oncological Outcomes
9%
Surgical Pathway
9%
Yorkshire
9%
Global Health Research
9%
British Association
9%
National Institute for Health Research
9%
COVID-19 Related
9%
COVID-19 Outbreak
9%
Case Notification Rate
9%
Long-term Investment
9%
Government Response Stringency Index
9%
Surge Capacity
9%
Government Response
9%
Response to COVID-19
9%
Stringency Index
9%
Systems Strengthening
9%
Operative Delay
9%
Medicine and Dentistry
Neoplasm
100%
COVID-19
100%
Prospective Cohort Study
100%
Cancer Surgery
100%
Hazard Ratio
37%
Cancer Research
25%
Coloproctology
25%
Malignant Neoplasm
12%
Female Genital Tract Cancer
12%
Public Health
12%
Emergency Care
12%
Surgeon
12%
Enteropathy
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Elective Surgery
12%
Neoadjuvant Therapy
12%
Proportional Hazards Model
12%
Cancer Types
12%
Urology
12%
Surgical Oncology
12%
Connective Tissue Cancer
12%